Detalhe da pesquisa
1.
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.
Breast Cancer Res Treat
; 147(3): 579-88, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25209003
2.
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Clin Cancer Res
; 30(4): 729-740, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38109213
3.
An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models.
Breast Cancer Res
; 15(5): R85, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24044505
4.
Phosphoprotein-based drug target activation mapping for precision oncology: a view to the future.
Expert Rev Proteomics
; 15(11): 851-853, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30301389
5.
Proteomic applications for the early detection of cancer.
Nat Rev Cancer
; 3(4): 267-75, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12671665
6.
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
NPJ Breast Cancer
; 9(1): 41, 2023 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210417
7.
Proteomic analysis of eccrine sweat: implications for the discovery of schizophrenia biomarker proteins.
J Proteome Res
; 11(4): 2127-39, 2012 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22256890
8.
Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines.
Int J Cancer
; 131(9): 1998-2007, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22328489
9.
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.
Mol Oncol
; 16(1): 104-115, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34437759
10.
Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors.
Cancers (Basel)
; 15(1)2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36612255
11.
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
NPJ Breast Cancer
; 8(1): 128, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456573
12.
Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
J Proteome Res
; 10(7): 3089-97, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21574647
13.
Validation of a multicellular tumor microenvironment system for modeling patient tumor biology and drug response.
Sci Rep
; 11(1): 5535, 2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33692370
14.
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial.
Cancer Cell
; 39(7): 989-998.e5, 2021 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34143979
15.
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
NPJ Breast Cancer
; 7(1): 131, 2021 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611148
16.
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
Nat Commun
; 12(1): 6428, 2021 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741023
17.
Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer.
J Pathol
; 218(4): 514-9, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19396842
18.
Antitumor effect of insulin-like growth factor-1 receptor inhibition in head and neck squamous cell carcinoma.
Laryngoscope
; 130(6): 1470-1478, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433065
19.
Development of a multicellular pancreatic tumor microenvironment system using patient-derived tumor cells.
Lab Chip
; 19(7): 1193-1204, 2019 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30839006
20.
Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL.
J Med Imaging (Bellingham)
; 5(1): 011014, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296631